A Systematic Review of Cost-Utility Analyses in HIV/AIDS: Implications for Public Policy
Author
Abstract
Suggested Citation
DOI: 10.1177/0272989X07306112
Download full text from publisher
References listed on IDEAS
- Duggan Mark G & Evans William N, 2008.
"Estimating the Impact of Medical Innovation: A Case Study of HIV Antiretroviral Treatments,"
Forum for Health Economics & Policy, De Gruyter, vol. 11(2), pages 1-39, January.
- Mark G. Duggan & William N. Evans, 2005. "Estimating the Impact of Medical Innovation: A Case Study of HIV Antiretroviral Treatments," NBER Working Papers 11109, National Bureau of Economic Research, Inc.
- Blumstein, James F., 1997. "The Oregon experiment: The role of cost-benefit analysis in the allocation of Medicaid funds," Social Science & Medicine, Elsevier, vol. 45(4), pages 545-554, August.
- Joseph M. Mrus & Michael S. Yi & Mark H. Eckman & Joel Tsevat, 2002. "The Impact of Expected HIV Transmission Rates on the Effectiveness and Cost of Ruling Out HIV Infection in Infants," Medical Decision Making, , vol. 22(1_suppl), pages 38-44, September.
- Kenneth A. Freedberg & W. David Hardy & Robert S. Holzman & Anna N.A. Tosteson & Donald E. Craven, 1996. "Validating Literature-based Models with Direct Clinical Trial Results," Medical Decision Making, , vol. 16(1), pages 29-35, February.
- Tammy O. Tengs, 1996. "An evaluation of Oregon's Medicaid rationing algorithms," Health Economics, John Wiley & Sons, Ltd., vol. 5(3), pages 171-181, May.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Daysal, N. Meltem & Trandafir, Mircea & van Ewijk, Reyn, 2019. "Low-risk isn’t no-risk: Perinatal treatments and the health of low-income newborns," Journal of Health Economics, Elsevier, vol. 64(C), pages 55-67.
- Frank Lichtenberg, 2006. "The Effect of Using Newer Drugs on Admissions of Elderly Americans to Hospitals and Nursing Homes: State-level Evidence from 1997 to 2003," PharmacoEconomics, Springer, vol. 24(3), pages 5-25, December.
- William N. Evans & Craig Garthwaite, 2012.
"Estimating Heterogeneity in the Benefits of Medical Treatment Intensity,"
The Review of Economics and Statistics, MIT Press, vol. 94(3), pages 635-649, August.
- William N. Evans & Craig L. Garthwaite, 2009. "Estimating Heterogeneity in the Benefits of Medical Treatment Intensity," NBER Working Papers 15309, National Bureau of Economic Research, Inc.
- Benjamin D. Sommers, 2017. "State Medicaid Expansions and Mortality, Revisited: A Cost-Benefit Analysis," American Journal of Health Economics, MIT Press, vol. 3(3), pages 392-421, Summer.
- Margaret K. Kyle, 2019. "The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals," NBER Chapters, in: Innovation Policy and the Economy, Volume 20, pages 95-123, National Bureau of Economic Research, Inc.
- Frank R. Lichtenberg, 2006. "The Impact of Increased Utilization of HIV Drugs on Longevity and Medical Expenditures: An Assessment Based on Aggregate U.S. Time-Series Data," NBER Working Papers 12406, National Bureau of Economic Research, Inc.
- Don Kenkel, 2006. "WTP- and QALY-Based Approaches to Valuing Health for Policy: Common Ground and Disputed Territory," Environmental & Resource Economics, Springer;European Association of Environmental and Resource Economists, vol. 34(3), pages 419-437, July.
- Amitabh Chandra & Jonathan S. Skinner, 2011. "Technology Growth and Expenditure Growth in Health Care," NBER Working Papers 16953, National Bureau of Economic Research, Inc.
- Frank Lichtenberg, 2011.
"The quality of medical care, behavioral risk factors, and longevity growth,"
International Journal of Health Economics and Management, Springer, vol. 11(1), pages 1-34, March.
- Frank R. Lichtenberg, 2009. "The Quality of Medical Care, Behavioral Risk Factors, and Longevity Growth," NBER Working Papers 15068, National Bureau of Economic Research, Inc.
- Abdülkadi̇r Ci̇van & Bülent Köksal, 2010.
"The effect of newer drugs on health spending: do they really increase the costs?,"
Health Economics, John Wiley & Sons, Ltd., vol. 19(5), pages 581-595, May.
- Civan, Abdülkadir & Koksal, Bulent, 2007. "The Effect of Newer Drugs on Health Spending: Do They Really Increase the Costs?," MPRA Paper 6846, University Library of Munich, Germany.
- Douglas K. Owens, 2002. "Analytic Tools for Public Health Decision Making," Medical Decision Making, , vol. 22(1_suppl), pages 3-10, September.
- Rebecca M. Henderson & Richard G. Newell, 2011.
"Accelerating Energy Innovation: Insights from Multiple Sectors,"
NBER Books,
National Bureau of Economic Research, Inc, number hend09-1.
- Rebecca Henderson & Richard G. Newell, 2010. "Accelerating Energy Innovation: Insights from Multiple Sectors," NBER Working Papers 16529, National Bureau of Economic Research, Inc.
- Daysal, N. Meltem & Trandafir, Mircea & van Ewijk, Reyn, 2016. "Heterogeneous Effects of Medical Interventions on the Health of Low-Risk Newborns," IZA Discussion Papers 9810, Institute of Labor Economics (IZA).
- Pedro Pita Barros & Xavier Martínez-Giralt, 2009.
"Technological adoption in health care,"
Working Papers
413, Barcelona School of Economics.
- Pedro Pita Barros & Xavier Martinez-Giralt, 2010. "Technological adoption in health care," Nova SBE Working Paper Series wp545, Universidade Nova de Lisboa, Nova School of Business and Economics.
- Pedro Pita Barros & Xavier Martinez-Giralt, 2009. "Technological adoption in health care," UFAE and IAE Working Papers 790.09, Unitat de Fonaments de l'Anàlisi Econòmica (UAB) and Institut d'Anàlisi Econòmica (CSIC).
- Martinez-Giralt, Xavier & Barros, Pedro, 2009. "Technological adoption in health care," CEPR Discussion Papers 7558, C.E.P.R. Discussion Papers.
- Christopher J.L. Murray & David B. Evans & Arnab Acharya & Rob M.P.M. Baltussen, 2000. "Development of WHO guidelines on generalized cost‐effectiveness analysis," Health Economics, John Wiley & Sons, Ltd., vol. 9(3), pages 235-251, April.
- Rebecca M. Henderson & Richard G. Newell, 2011. "Introduction and Summary to "Accelerating Energy Innovation: Insights from Multiple Sectors"," NBER Chapters, in: Accelerating Energy Innovation: Insights from Multiple Sectors, pages 1-23, National Bureau of Economic Research, Inc.
- Dolan, Paul & Tsuchiya, Aki, 2005. "Health priorities and public preferences: the relative importance of past health experience and future health prospects," Journal of Health Economics, Elsevier, vol. 24(4), pages 703-714, July.
- Stephanie R. Earnshaw & Anke Richter & Stephen W. Sorensen & Thomas J. Hoerger & Katherine A. Hicks & Michael Engelgau & Ted Thompson & K. M. Venkat Narayan & David F. Williamson & Edward Gregg & Ping, 2002. "Optimal Allocation of Resources across Four Interventions for Type 2 Diabetes," Medical Decision Making, , vol. 22(1_suppl), pages 80-91, September.
- Onwujekwe, Obinna & Dike, Nkem & Chukwuka, Chinwe & Uzochukwu, Benjamin & Onyedum, Cajetan & Onoka, Chima & Ichoku, Hyacinth, 2009. "Examining catastrophic costs and benefit incidence of subsidized antiretroviral treatment (ART) programme in south-east Nigeria," Health Policy, Elsevier, vol. 90(2-3), pages 223-229, May.
- Williams, Iestyn P. & Bryan, Stirling, 2007. "Cost-effectiveness analysis and formulary decision making in England: Findings from research," Social Science & Medicine, Elsevier, vol. 65(10), pages 2116-2129, November.
More about this item
Keywords
Key words: HIV; economics; cost and cost analyses; cost-utility; public policy.;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:medema:v:27:y:2007:i:6:p:789-821. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.